Skip to main content
. 2024 Jan 18;24:102. doi: 10.1186/s12879-023-08839-z

Table 6.

Explanatory variables for cellulitis related to the severity of lymphoedema of the arm, a sub-group analysis (n = 460)

No cellulitis
N (%)
Cellulitis
N (%)
OR 95%CI P-value
Pitting (n = 459)
 Non pitting 232 (58.44) 29 (46.77) 1.00
 Pitting 165 (41.56) 33 (53.23) 1.60 (0.93, 2.74) 0.085
Tissue quality (n = 459)
 Soft 314 (79.09) 42 (67.74) 1.00
 Hard (fibrotic) 83 (20.91) 20 (32.26) 1.80 (1.00, 3.23) 0.046
Stemmer’s sign (n = 458)
 Negative 217 (54.80) 18 (29.03) 1.00
 Positive 179 (45.20) 44 (70.97) 2.96 (1.65, 5.31) < 0.001
ISL scale* (n = 460)
 Stage I 139 (34.92) 5 (8.06) 1.00
 Stage II 240 (60.30) 50 (80.65) 5.79 (2.26, 14.87) < 0.001
 Stage III 19 (4.77) 7 (11.29) 10.24 (2.95, 35.53)
ISL scale* after adjustment for lymphoedema duration and control by logistic regression (n = 326)
 Stage I 1.00
 Stage II 5.44 (1.59, 18.60) 0.002
 Stage III 9.13 (1.99, 41.84)

*ISL scale = International Society of Lymphology scale (assessment of severity of chronic edema/lymphedema). ISL stage I: Early onset of the condition, with an accumulation of tissue edema that decreases with limb elevation. The edema may be pitting at this stage. ISL stage II: Limb elevation alone rarely reduces swelling and pitting is manifested. ISL stage III: The tissue is fibrotic and pitting is absent. Skin changes such as thickening, hyperpigmentation, increased skin folds, fat deposits, and warty overgrowths develop